Catheter-directed therapy with the FlowTriever system for intermediate-high and high-risk pulmonary embolism: a single-centre experience
2024

FlowTriever System for Treating Pulmonary Embolism

Sample size: 21 publication Evidence: moderate

Author Information

Author(s): Hart Einar A., Eenhoorn Paul, Nijkeuter Mathilde, Ruigrok Dieuwertje, van der Heijden Joris J., Voskuil Michiel, Liu Tommy K. K., Balder Jan Willem, van de Hoef Tim P., van der Harst Pim, Kraaijeveld Adriaan O., Dickinson Michael G.

Primary Institution: University Medical Centre Utrecht

Hypothesis

Can the FlowTriever thrombosuction system serve as a safe alternative to systemic thrombolysis in high-risk pulmonary embolism patients?

Conclusion

The FlowTriever thrombosuction system appears to be a minimally invasive alternative treatment for high-risk pulmonary embolism with low complication rates.

Supporting Evidence

  • The technical success rate of the FlowTriever system was 100%.
  • 30-day all-cause mortality was 29%.
  • Major bleeding occurred in 24% of patients, with one event related to the FlowTriever procedure.
  • A significant reduction in mean pulmonary arterial pressure was observed.
  • Reduction in right ventricular end-diastolic dimension was also noted.

Takeaway

Doctors used a special device called FlowTriever to help patients with serious blood clots in their lungs, and it worked really well without causing many problems.

Methodology

This was a single-centre retrospective cohort study analyzing data from patients treated with the FlowTriever system from December 2021 to March 2024.

Potential Biases

The study included patients with high-risk factors and those who had contraindications for standard treatment, which may introduce bias.

Limitations

The study had a modest sample size, single-arm design, and variability in available data, which may affect the conclusions.

Participant Demographics

The cohort included 21 patients, with 14 classified as high risk and 7 as intermediate-high risk, including a significant number presenting with circulatory arrest.

Statistical Information

P-Value

0.012

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1007/s12471-024-01916-1

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication